{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T12:11:14Z","timestamp":1777723874937,"version":"3.51.4"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Head and Neck Pathol"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s12105-022-01411-2","type":"journal-article","created":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T16:02:41Z","timestamp":1647878561000},"page":"101-109","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Hematolymphoid Proliferations and Neoplasia"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3428-4166","authenticated-orcid":false,"given":"Judith A.","family":"Ferry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,21]]},"reference":[{"key":"1411_CR1","volume-title":"Head and neck tumours","author":"WHO Classification of Tumours Editorial Board","year":"2022","unstructured":"WHO Classification of Tumours Editorial Board. Head and neck tumours. Lyon: International Agency for Research on Cancer; 2022."},{"key":"1411_CR2","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/modpathol.2012.70","volume":"25","author":"A Louissaint Jr","year":"2012","unstructured":"Louissaint A Jr, Ferry JA, Soupir CP, Hasserjian RP, Harris NL, Zukerberg LR. Infectious mononucleosis mimicking lymphoma: distinguishing morphological and immunophenotypic features. Mod Pathol. 2012;25:1149\u201359.","journal-title":"Mod Pathol"},{"key":"1411_CR3","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0194-5998(02)23291-X","volume":"128","author":"H Lin","year":"2003","unstructured":"Lin H, Su C, Huang C, Hwang C, Chien C. Kikuchi\u2019s disease: a review and analysis of 61 cases. Otolaryngol Head Neck Surg. 2003;128:650\u20133.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"1411_CR4","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1097\/00000478-199507000-00008","volume":"19","author":"T Kuo","year":"1995","unstructured":"Kuo T. Kikuchi\u2019s disease (histiocytic necrotizing lymphadenitis). A clinicopathologic study of 79 cases with an analysis of histologic subtypes, immunohistology and DNA ploidy. Am J Surg Pathol. 1995;19:798\u2013809.","journal-title":"Am J Surg Pathol"},{"key":"1411_CR5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/00000478-199403000-00001","volume":"18","author":"WYW Tsang","year":"1994","unstructured":"Tsang WYW, Chan JKC, Ng CS. Kikuchi\u2019s lymphadenitis. A morphologic analysis of 75 cases with special reference to unusual features. Am J Surg Pathol. 1994;18:219\u201331.","journal-title":"Am J Surg Pathol"},{"key":"1411_CR6","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1182\/blood-2004-01-0385","volume":"104","author":"AD Attygalle","year":"2004","unstructured":"Attygalle AD, Liu H, Shirali S, et al. Atypical marginal zone hyperplasia of mucosa-associated lymphoid tissue: a reactive condition of childhood showing immunoglobulin lambda light-chain restriction. Blood. 2004;104:3343\u20138.","journal-title":"Blood"},{"key":"1411_CR7","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/MPH.0000000000000494","volume":"38","author":"SS Elicora","year":"2016","unstructured":"Elicora SS, Guven M, Varli AF, Yilmaz MS, Alponat S. Rare posterior pharyngeal mass: atypical marginal zone hyperplasia. J Pediatr Hematol Oncol. 2016;38:152\u20134.","journal-title":"J Pediatr Hematol Oncol"},{"key":"1411_CR8","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ajh.22132","volume":"87","author":"P Kaur","year":"2012","unstructured":"Kaur P, Levy NB. Atypical marginal zone hyperplasia of tonsil with immunoglobulin light chain restriction. Am J Hematol. 2012;87:424\u20135.","journal-title":"Am J Hematol"},{"key":"1411_CR9","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/PAS.0b013e3181cf8622","volume":"34","author":"SD Dojcinov","year":"2010","unstructured":"Dojcinov SD, Venkataraman G, Raffeld M, Pittaluga S, Jaffe ES. EBV positive mucocutaneous ulcer--a study of 26 cases associated with various sources of immunosuppression. Am J Surg Pathol. 2010;34:405\u201317.","journal-title":"Am J Surg Pathol"},{"key":"1411_CR10","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1097\/PAS.0000000000000282","volume":"38","author":"M Hart","year":"2014","unstructured":"Hart M, Thakral B, Yohe S, et al. EBV-positive mucocutaneous ulcer in organ transplant recipients: a localized indolent posttransplant lymphoproliferative disorder. Am J Surg Pathol. 2014;38:1522\u20139.","journal-title":"Am J Surg Pathol"},{"key":"1411_CR11","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/PAS.0b013e3181c811ad","volume":"34","author":"JT Geyer","year":"2010","unstructured":"Geyer JT, Ferry JA, Harris NL, et al. Chronic sclerosing sialadenitis (Kuttner tumor) is an IgG4-associated disease. Am J Surg Pathol. 2010;34:202\u201310.","journal-title":"Am J Surg Pathol"},{"key":"1411_CR12","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1097\/PAS.0000000000000497","volume":"39","author":"JA Ferry","year":"2015","unstructured":"Ferry JA, Klepeis V, Sohani AR, et al. IgG4-related orbital disease and its mimics in a western population. Am J Surg Pathol. 2015;39:1688\u2013700.","journal-title":"Am J Surg Pathol"},{"key":"1411_CR13","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1053\/j.semdp.2012.07.008","volume":"29","author":"JA Ferry","year":"2012","unstructured":"Ferry JA, Deshpande V. IgG4-related disease in the head and neck. Semin Diagn Pathol. 2012;29:235\u201344.","journal-title":"Semin Diagn Pathol"},{"key":"1411_CR14","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","volume":"25","author":"V Deshpande","year":"2012","unstructured":"Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25:1181\u201392.","journal-title":"Mod Pathol"},{"key":"1411_CR15","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1053\/j.semdp.2012.08.001","volume":"29","author":"V Deshpande","year":"2012","unstructured":"Deshpande V. The pathology of IgG4-related disease: critical issues and challenges. Semin Diagn Pathol. 2012;29:191\u20136.","journal-title":"Semin Diagn Pathol"},{"key":"1411_CR16","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/PAS.0b013e318213889e","volume":"35","author":"V Deshpande","year":"2011","unstructured":"Deshpande V, Khosroshahi A, Nielsen GP, Hamilos DL, Stone JH. Eosinophilic angiocentric fibrosis is a form of IgG4-related systemic disease. Am J Surg Pathol. 2011;35:701\u20136.","journal-title":"Am J Surg Pathol"},{"key":"1411_CR17","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.5858\/arpa.2017-0223-RS","volume":"142","author":"J Ahn","year":"2018","unstructured":"Ahn J, Flanagan M. Eosinophilic angiocentric fibrosis: a review and update of its association with immunoglobulin G4-related disease. Arch Pathol Lab Med. 2018;142:1560\u20133.","journal-title":"Arch Pathol Lab Med"},{"key":"1411_CR18","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s12105-020-01272-7","volume":"15","author":"LDR Thompson","year":"2021","unstructured":"Thompson LDR. Algorithmic approach to fibroinflammatory sinonasal tract lesions. Head Neck Pathol. 2021;15:120\u20139.","journal-title":"Head Neck Pathol"},{"key":"1411_CR19","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3324\/haematol.2011.042531","volume":"96","author":"H Horn","year":"2011","unstructured":"Horn H, Schmelter C, Leich E, et al. Follicular lymphoma grade 3B is a distinct neoplasm according to cytogenetic and immunohistochemical profiles. Haematologica. 2011;96:1327\u201334.","journal-title":"Haematologica"},{"key":"1411_CR20","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1182\/blood-2012-05-429514","volume":"120","author":"A Louissaint Jr","year":"2012","unstructured":"Louissaint A Jr, Ackerman AM, Dias-Santagata D, et al. Pediatric-type nodal follicular lymphoma: an indolent clonal proliferation in children and adults with high proliferation index and no BCL2 rearrangement. Blood. 2012;120:2395\u2013404.","journal-title":"Blood"},{"key":"1411_CR21","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1182\/blood-2015-12-682591","volume":"128","author":"A Louissaint Jr","year":"2016","unstructured":"Louissaint A Jr, Schafernak KT, Geyer JT, et al. Pediatric-type nodal follicular lymphoma: a biologically distinct lymphoma with frequent MAPK pathway mutations. Blood. 2016;128:1093\u2013100.","journal-title":"Blood"},{"key":"1411_CR22","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00428-019-02681-y","volume":"475","author":"C Agostinelli","year":"2019","unstructured":"Agostinelli C, Akarca AU, Ramsay A, et al. Novel markers in pediatric-type follicular lymphoma. Virchows Arch. 2019;475:771\u20139.","journal-title":"Virchows Arch"},{"key":"1411_CR23","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1182\/blood-2017-03-776278","volume":"130","author":"J Schmidt","year":"2017","unstructured":"Schmidt J, Ramis-Zaldivar JE, Nadeu F, et al. Mutations of MAP2K1 are frequent in pediatric-type follicular lymphoma and result in ERK pathway activation. Blood. 2017;130:323\u20137.","journal-title":"Blood"},{"key":"1411_CR24","doi-asserted-by":"crossref","first-page":"e28416","DOI":"10.1002\/pbc.28416","volume":"67","author":"A Attarbaschi","year":"2020","unstructured":"Attarbaschi A, Abla O, Arias Padilla L, et al. Rare non-Hodgkin lymphoma of childhood and adolescence: a consensus diagnostic and therapeutic approach to pediatric-type follicular lymphoma, marginal zone lymphoma, and nonanaplastic peripheral T-cell lymphoma. Pediatr Blood Cancer. 2020;67:e28416.","journal-title":"Pediatr Blood Cancer"},{"key":"1411_CR25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1182\/blood-2011-01-330795","volume":"118","author":"I Salaverria","year":"2011","unstructured":"Salaverria I, Philipp C, Oschlies I, et al. Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults. Blood. 2011;118:139\u201347.","journal-title":"Blood"},{"key":"1411_CR26","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/bjh.16578","volume":"190","author":"RKH Au-Yeung","year":"2020","unstructured":"Au-Yeung RKH, Arias Padilla L, Zimmermann M, et al. Experience with provisional WHO-entities large B-cell lymphoma with IRF4-rearrangement and Burkitt-like lymphoma with 11q aberration in paediatric patients of the NHL-BFM group. Br J Haematol. 2020;190:753\u201363.","journal-title":"Br J Haematol"},{"key":"1411_CR27","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.3324\/haematol.2018.191601","volume":"103","author":"S Moody","year":"2018","unstructured":"Moody S, Thompson JS, Chuang SS, et al. Novel GPR34 and CCR6 mutation and distinct genetic profiles in MALT lymphomas of different sites. Haematologica. 2018;103:1329\u201336.","journal-title":"Haematologica"},{"key":"1411_CR28","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/path.2466","volume":"217","author":"E Chanudet","year":"2009","unstructured":"Chanudet E, Ye H, Ferry J, et al. A20 deletion is associated with copy number gain at the TNFA\/B\/C locus and occurs preferentially in translocation-negative MALT lymphoma of the ocular adnexa and salivary glands. J Pathol. 2009;217:420\u201330.","journal-title":"J Pathol"},{"key":"1411_CR29","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/leu.2009.234","volume":"24","author":"E Chanudet","year":"2010","unstructured":"Chanudet E, Huang Y, Ichimura K, et al. A20 is targeted by promoter methylation, deletion and inactivating mutation in MALT lymphoma. Leukemia. 2010;24:483\u20137.","journal-title":"Leukemia"},{"key":"1411_CR30","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.3324\/haematol.2018.196998","volume":"103","author":"JA Martinez-Climent","year":"2018","unstructured":"Martinez-Climent JA. G-protein coupled receptor (GPCR) mutations in lymphoid malignancies: linking immune signaling activation and genetic abnormalities. Haematologica. 2018;103:1252\u20135.","journal-title":"Haematologica"},{"key":"1411_CR31","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00428-021-03022-8","volume":"479","author":"SM Aukema","year":"2021","unstructured":"Aukema SM, Croci GA, Bens S, et al. Mantle cell lymphomas with concomitant MYC and CCND1 breakpoints are recurrently TdT positive and frequently show high-grade pathological and genetic features. Virchows Arch. 2021;479:133\u201345.","journal-title":"Virchows Arch"},{"key":"1411_CR32","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/bjh.17419","volume":"195","author":"E Silkenstedt","year":"2021","unstructured":"Silkenstedt E, Linton K, Dreyling M. Mantle cell lymphoma\u2014advances in molecular biology, prognostication and treatment approaches. Br J Haematol. 2021;195:162\u201373.","journal-title":"Br J Haematol"},{"key":"1411_CR33","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1182\/bloodadvances.2019001350","volume":"4","author":"HA Hill","year":"2020","unstructured":"Hill HA, Qi X, Jain P, et al. Genetic mutations and features of mantle cell lymphoma: a systematic review and meta-analysis. Blood Adv. 2020;4:2927\u201338.","journal-title":"Blood Adv"},{"key":"1411_CR34","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.3324\/haematol.2019.243071","volume":"106","author":"L Wang","year":"2021","unstructured":"Wang L, Tang G, Medeiros LJ, et al. MYC rearrangement but not extra MYC copies is an independent prognostic factor in patients with mantle cell lymphoma. Haematologica. 2021;106:1381\u20139.","journal-title":"Haematologica"},{"key":"1411_CR35","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1182\/blood-2012-08-452284","volume":"121","author":"I Salaverria","year":"2013","unstructured":"Salaverria I, Royo C, Carvajal-Cuenca A, et al. CCND2 rearrangements are the most frequent genetic events in cyclin D1(-) mantle cell lymphoma. Blood. 2013;121:1394\u2013402.","journal-title":"Blood"},{"key":"1411_CR36","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1182\/blood-2018-07-862151","volume":"133","author":"D Martin-Garcia","year":"2019","unstructured":"Martin-Garcia D, Navarro A, Valdes-Mas R, et al. CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1(\u2013) mantle cell lymphoma. Blood. 2019;133:940\u201351.","journal-title":"Blood"},{"key":"1411_CR37","doi-asserted-by":"crossref","first-page":"e202-e5","DOI":"10.3324\/haematol.2018.208140","volume":"105","author":"R Wagener","year":"2020","unstructured":"Wagener R, Bens S, Toprak UH, et al. Cryptic insertion of MYC exons 2 and 3 into the immunoglobulin heavy chain locus detected by whole genome sequencing in a case of \u201cMYC-negative\u201d Burkitt lymphoma. Haematologica. 2020;105:e202-e5.","journal-title":"Haematologica"},{"key":"1411_CR38","doi-asserted-by":"crossref","unstructured":"Schmitz R, Ceribelli M, Pittaluga S, Wright G, Staudt LM. Oncogenic mechanisms in Burkitt lymphoma. Cold Spring Harb Perspect Med 2014;4.","DOI":"10.1101\/cshperspect.a014282"},{"key":"1411_CR39","doi-asserted-by":"crossref","first-page":"e1005158","DOI":"10.1371\/journal.ppat.1005158","volume":"11","author":"F Abate","year":"2015","unstructured":"Abate F, Ambrosio MR, Mundo L, et al. Distinct viral and mutational spectrum of endemic burkitt lymphoma. PLoS Pathog. 2015;11:e1005158.","journal-title":"PLoS Pathog"},{"key":"1411_CR40","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.beha.2010.08.002","volume":"23","author":"JP Meijerink","year":"2010","unstructured":"Meijerink JP. Genetic rearrangements in relation to immunophenotype and outcome in T-cell acute lymphoblastic leukaemia. Best Pract Res Clin Haematol. 2010;23:307\u201318.","journal-title":"Best Pract Res Clin Haematol"},{"key":"1411_CR41","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1365-2141.2008.07314.x","volume":"143","author":"P Van Vlierberghe","year":"2008","unstructured":"Van Vlierberghe P, Pieters R, Beverloo HB, Meijerink JP. Molecular-genetic insights in paediatric T-cell acute lymphoblastic leukaemia. Br J Haematol. 2008;143:153\u201368.","journal-title":"Br J Haematol"},{"key":"1411_CR42","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/leu.2015.203","volume":"30","author":"ST Balbach","year":"2016","unstructured":"Balbach ST, Makarova O, Bonn BR, et al. Proposal of a genetic classifier for risk group stratification in pediatric T-cell lymphoblastic lymphoma reveals differences from adult T-cell lymphoblastic leukemia. Leukemia. 2016;30:970\u20133.","journal-title":"Leukemia"},{"key":"1411_CR43","doi-asserted-by":"crossref","unstructured":"Bongiovanni D, Saccomani V, Piovan E. Aberrant signaling pathways in T-cell acute lymphoblastic leukemia. Int J Mol Sci 2017;18.","DOI":"10.3390\/ijms18091904"},{"key":"1411_CR44","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1182\/blood.2019004547","volume":"137","author":"P Anand","year":"2021","unstructured":"Anand P, Guillaumet-Adkins A, Dimitrova V, et al. Single-cell RNA-seq reveals developmental plasticity with coexisting oncogenic states and immune evasion programs in ETP-ALL. Blood. 2021;137:2463\u201380.","journal-title":"Blood"},{"key":"1411_CR45","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1182\/blood.2020005381","volume":"137","author":"T Khanam","year":"2021","unstructured":"Khanam T, Sandmann S, Seggewiss J, et al. Integrative genomic analysis of pediatric T-cell lymphoblastic lymphoma reveals candidates of clinical significance. Blood. 2021;137:2347\u201359.","journal-title":"Blood"},{"key":"1411_CR46","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3389\/fonc.2019.00683","volume":"9","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Xu Z, Lin W, et al. Comprehensive genomic profiling of EBV-positive diffuse large B-cell lymphoma and the expression and clinicopathological correlations of some related genes. Front Oncol. 2019;9:683.","journal-title":"Front Oncol"},{"key":"1411_CR47","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/bjh.14633","volume":"178","author":"T Menter","year":"2017","unstructured":"Menter T, Juskevicius D, Alikian M, et al. Mutational landscape of B-cell post-transplant lymphoproliferative disorders. Br J Haematol. 2017;178:48\u201356.","journal-title":"Br J Haematol"},{"key":"1411_CR48","doi-asserted-by":"crossref","first-page":"107356","DOI":"10.18632\/oncotarget.22219","volume":"8","author":"MR Ambrosio","year":"2017","unstructured":"Ambrosio MR, Mundo L, Gazaneo S, et al. MicroRNAs sequencing unveils distinct molecular subgroups of plasmablastic lymphoma. Oncotarget. 2017;8:107356\u201373.","journal-title":"Oncotarget"},{"key":"1411_CR49","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ccell.2020.02.005","volume":"37","author":"J Xiong","year":"2020","unstructured":"Xiong J, Cui BW, Wang N, et al. Genomic and transcriptomic characterization of natural killer T cell lymphoma. Cancer Cell. 2020;37:403\u201319.","journal-title":"Cancer Cell"},{"key":"1411_CR50","doi-asserted-by":"crossref","first-page":"e1263-e72","DOI":"10.1002\/onco.13801","volume":"26","author":"LR Massoth","year":"2021","unstructured":"Massoth LR, Hung YP, Ferry JA, et al. Histiocytic and dendritic cell sarcomas of hematopoietic origin share targetable genomic alterations distinct from follicular dendritic cell sarcoma. Oncologist. 2021;26:e1263\u201372.","journal-title":"Oncologist"},{"key":"1411_CR51","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1038\/s41591-019-0653-6","volume":"25","author":"BH Durham","year":"2019","unstructured":"Durham BH, Lopez Rodrigo E, Picarsic J, et al. Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms. Nat Med. 2019;25:1839\u201342.","journal-title":"Nat Med"},{"key":"1411_CR52","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/modpathol.2017.50","volume":"30","author":"CN Paxton","year":"2017","unstructured":"Paxton CN, O\u2019Malley DP, Bellizzi AM, et al. Genetic evaluation of juvenile xanthogranuloma: genomic abnormalities are uncommon in solitary lesions, advanced cases may show more complexity. Mod Pathol. 2017;30:1234\u201340.","journal-title":"Mod Pathol"},{"key":"1411_CR53","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1182\/blood-2012-05-430140","volume":"120","author":"J Haroche","year":"2012","unstructured":"Haroche J, Charlotte F, Arnaud L, et al. High prevalence of BRAF V600E mutations in Erdheim\u2013Chester disease but not in other non-Langerhans cell histiocytoses. Blood. 2012;120:2700\u20133.","journal-title":"Blood"},{"key":"1411_CR54","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1158\/2159-8290.CD-15-0913","volume":"6","author":"EL Diamond","year":"2016","unstructured":"Diamond EL, Durham BH, Haroche J, et al. Diverse and targetable kinase alterations drive histiocytic neoplasms. Cancer Discov. 2016;6:154\u201365.","journal-title":"Cancer Discov"},{"key":"1411_CR55","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/modpathol.2017.160","volume":"31","author":"N Ozkaya","year":"2018","unstructured":"Ozkaya N, Rosenblum MK, Durham BH, et al. The histopathology of Erdheim\u2013Chester disease: a comprehensive review of a molecularly characterized cohort. Mod Pathol. 2018;31:581\u201397.","journal-title":"Mod Pathol"},{"key":"1411_CR56","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/modpathol.2017.55","volume":"30","author":"S Garces","year":"2017","unstructured":"Garces S, Medeiros LJ, Patel KP, et al. Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai\u2013Dorfman disease. Mod Pathol. 2017;30:1367\u201377.","journal-title":"Mod Pathol"},{"key":"1411_CR57","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/bjh.16006","volume":"186","author":"E Baraban","year":"2019","unstructured":"Baraban E, Sadigh S, Rosenbaum J, et al. Cyclin D1 expression and novel mutational findings in Rosai\u2013Dorfman disease. Br J Haematol. 2019;186:837\u201344.","journal-title":"Br J Haematol"},{"key":"1411_CR58","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a034892","author":"R Chakraborty","year":"2021","unstructured":"Chakraborty R, Abdel-Wahab O, Durham BH. MAP-kinase-driven hematopoietic neoplasms: a decade of progress in the molecular Age. Cold Spring Harb Perspect Med. 2021. https:\/\/doi.org\/10.1101\/cshperspect.a034892.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1411_CR59","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1182\/blood-2018-03-839753","volume":"131","author":"O Abla","year":"2018","unstructured":"Abla O, Jacobsen E, Picarsic J, et al. Consensus recommendations for the diagnosis and clinical management of Rosai\u2013Dorfman\u2013Destombes disease. Blood. 2018;131:2877\u201390.","journal-title":"Blood"}],"container-title":["Head and Neck Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12105-022-01411-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12105-022-01411-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12105-022-01411-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T15:33:05Z","timestamp":1650468785000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12105-022-01411-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["1411"],"URL":"https:\/\/doi.org\/10.1007\/s12105-022-01411-2","relation":{},"ISSN":["1936-0568"],"issn-type":[{"value":"1936-0568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"9 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author declares that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not applicable for this review.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}